A detailed history of First Trust Advisors LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 117,864 shares of PCVX stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,864
Previous 78,926 49.33%
Holding current value
$10.3 Million
Previous $5.96 Million 125.81%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$70.52 - $117.12 $2.75 Million - $4.56 Million
38,938 Added 49.33%
117,864 $13.5 Million
Q2 2024

Aug 13, 2024

BUY
$60.06 - $78.77 $906,906 - $1.19 Million
15,100 Added 23.66%
78,926 $5.96 Million
Q1 2024

May 13, 2024

SELL
$59.79 - $81.05 $825,699 - $1.12 Million
-13,810 Reduced 17.79%
63,826 $4.36 Million
Q4 2023

Feb 13, 2024

BUY
$45.35 - $63.41 $2.04 Million - $2.85 Million
44,923 Added 137.32%
77,636 $4.88 Million
Q3 2023

Nov 13, 2023

SELL
$46.0 - $53.1 $123,786 - $142,892
-2,691 Reduced 7.6%
32,713 $1.67 Million
Q2 2023

Aug 14, 2023

SELL
$34.66 - $54.07 $62,595 - $97,650
-1,806 Reduced 4.85%
35,404 $1.77 Million
Q1 2023

May 15, 2023

BUY
$36.27 - $47.2 $607,486 - $790,552
16,749 Added 81.86%
37,210 $1.39 Million
Q4 2022

Feb 09, 2023

BUY
$20.58 - $47.95 $421,087 - $981,104
20,461 New
20,461 $981,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.18B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.